Randomized study of anti-coagulant therapy to preventpostoperative deep venous thrombosis/pulmonary embolism

Randomized study of anti-coagulant therapy to preventpostoperative deep venous thrombosis/pulmonary embolism - Randomized study of anti-coagulant therapy to preventpostoperative deep venous thrombosis/pulmonary embolism

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002444

Enrollment

300

Registered

2009-10-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after diegstive surgery classified high risk in DVT/PE prevention guide line

Interventions

enoxaparin 2000IU 2/day 7days fondaparinux 2.5mg 1/day 7says heparin sodium 5000IU 2/day 7days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1

Exclusion criteria

Exclusion criteria: 1

Design outcomes

Primary

Measure	Time frame
frequency of VTE	—

Secondary

Measure	Time frame
freqauency of adverse events including hemorrhage and abnormal seroligical findings	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026